Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 2
1995 2
1996 2
1997 1
1998 2
1999 2
2000 3
2004 2
2007 2
2009 3
2010 3
2011 7
2012 6
2013 2
2014 7
2015 5
2016 5
2017 10
2018 6
2019 7
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Cystic fibrosis year in review 2016.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2017 Aug;52(8):1092-1102. doi: 10.1002/ppul.23747. Epub 2017 Jun 13. Pediatr Pulmonol. 2017. PMID: 28608632 Review.
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation.
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR. Farrell PM, et al. Among authors: mccolley sa. J Pediatr. 2017 Feb;181S:S4-S15.e1. doi: 10.1016/j.jpeds.2016.09.064. J Pediatr. 2017. PMID: 28129811 Free article.
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: mccolley sa. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.
Cystic fibrosis year in review 2018, part 1.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Aug;54(8):1117-1128. doi: 10.1002/ppul.24361. Epub 2019 May 20. Pediatr Pulmonol. 2019. PMID: 31106528 Review.
The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis.
Talamo Guevara M, McColley SA. Talamo Guevara M, et al. Among authors: mccolley sa. Expert Opin Drug Saf. 2017 Nov;16(11):1305-1311. doi: 10.1080/14740338.2017.1372419. Epub 2017 Sep 21. Expert Opin Drug Saf. 2017. PMID: 28846049 Free PMC article. Review.
Diagnosis of Cystic Fibrosis in Screened Populations.
Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA. Farrell PM, et al. Among authors: mccolley sa. J Pediatr. 2017 Feb;181S:S33-S44.e2. doi: 10.1016/j.jpeds.2016.09.065. J Pediatr. 2017. PMID: 28129810 Free article.
The demographics of adverse outcomes in cystic fibrosis.
McGarry ME, Williams WA 2nd, McColley SA. McGarry ME, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S74-S83. doi: 10.1002/ppul.24434. Pediatr Pulmonol. 2019. PMID: 31715087 Review.
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS. McNamara JJ, et al. Among authors: mccolley sa. Lancet Respir Med. 2019 Apr;7(4):325-335. doi: 10.1016/S2213-2600(18)30460-0. Epub 2019 Jan 24. Lancet Respir Med. 2019. PMID: 30686767 Clinical Trial.
Cystic fibrosis year in review 2018, part 2.
Savant AP, McColley SA. Savant AP, et al. Among authors: mccolley sa. Pediatr Pulmonol. 2019 Aug;54(8):1129-1140. doi: 10.1002/ppul.24365. Epub 2019 May 24. Pediatr Pulmonol. 2019. PMID: 31125191 Review.
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D; VX09-809-102 study group. Boyle MP, et al. Among authors: mccolley sa. Lancet Respir Med. 2014 Jul;2(7):527-38. doi: 10.1016/S2213-2600(14)70132-8. Epub 2014 Jun 24. Lancet Respir Med. 2014. PMID: 24973281 Clinical Trial.
80 results
Jump to page
Feedback